Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine monitoring in risperidone-induced hyperprolactinemia in schizophrenia
2005-006037-33Phase 3Active
- Sponsor
- Universitätsklinikum Bonn
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bromocriptine in hyperprolactinemia, sponsored by Universitätsklinikum Bonn. Primary endpoint: Hormonal efficacy. Started Sep 2006; status: active.
02
Drugs
bromocriptine
03
Conditions
hyperprolactinemia
Beyond the preview
Go deeper on 2005-006037-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006037-33.